Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Insulin Affordability and the Inflation Reduction Act: Medicare Beneficiary Savings by State and Demographics

Publication Date
Authors
Bisma A. Sayed, Kenneth Finegold, T. Anders Olsen, Nancy De Lew, Steven Sheingold, Kaavya Ashok, and Benjamin D. Sommers.

Effective January 1, 2023, out-of-pocket costs for insulin are capped at $35 per monthly prescription among Medicare Part D enrollees under the Inflation Reduction Act (IRA). A similar cap takes effect in Medicare Part B on July 1, 2023. An estimated 1.5 million Medicare beneficiaries who use insulin would have saved $734 million in Part D and $27 million in Part B if these caps had been in effect in 2020.

*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Kenneth Finegold, (202) 557-9553, Kenneth.Finegold@hhs.gov. Content will be updated pending the outcome of the Section 508 review.

Related Content:

Product Type
ASPE Data Point
Populations
Older Adults
Location- & Geography-Based Data
National Data | State Data
Program
Medicare | Medicare Part B | Medicare Part D